VIJAYAWADA: Amrita University, run by Mata Amritanandamayi Trust, has come forward to set up a world-class medical university at Amaravati, the new Capital region of Andhra Pradesh.
The Trust will also set up a 2,250-bedded “multi super speciality” hospital, research and healthcare complex attached to the university, a communication from the Chief Minister’s Office said.
Representatives of Mata Amritanandamayi Institute of Medical Sciences met Andhra Pradesh Chief Minister N Chandrababu Naidu here this evening and discussed the proposals, it added.
They also submitted a detailed project report to the Chief Minister.
The “mega project” would be taken up at a cost of Rs 2,500 crore, the CMO said, adding that Naidu had earlier requested Mata Amritanandamayi to set up the medical university in the new Capital region.
This would be the second mega project in the medical and health sector in the Capital region as a British firm already came forward with a plan to set up a health city, the CMO communication said.
The prestigious All India Institute of Medical Sciences is also coming up at Mangalagiri that forms part of the capital region.
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
0 Comments
Post a comment
No comments yet. Be the first to comment!